HHLR ADVISORS, LTD.
13F Holdings and Portfolio Analysis
Zhang Lei 2021 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
HHLR ADVISORS, LTD. Overview
HHLR ADVISORS, LTD. held 91 stocks in 2021 Q1, with total market value around $10.12B.
HHLR ADVISORS, LTD.'s top five holdings in 2021 Q1: BeOne Medicines AG(ONC) 18.82%, PDD HOLDINGS INC COMMON STOCK(PDD) 13.53%, iQIYI, Inc.(IQ) 6.35%, ZOOM VIDEO COMMUNICATIONS IN 6.27%, ENSTAR GROUP LIMITED(ESGR) 4.26%.
- Portfolio Value
- $10.12B
- Current Holdings
- 91 stocks
- New / Increased
- 13 / 9
- Reduced / Exited
- 29 / 17
Current Holdings
| 1 | BeOne Medicines AGONC | 1.90 | 18.82% | 5.47 - | $348.08 | $316.42 -9.10% | $136.90 | 0.00 | 2.50 | +$0.98B+131.14% | Held |
| 2 | PDD HOLDINGS INC COMMON STOCKPDD | 1.37 | 13.53% | 10.22 -0.07% | $133.88 | $88.14 -34.16% | $34.21 | -0.01 | 2.50 | +$0.55B+157.66% | Reduced |
| 3 | iQIYI, Inc.IQ | 0.64 | 6.35% | 38.65 - | $16.62 | $2.03 -87.79% | $18.04 | 0.00 | 2.50 | -$0.62B-88.75% | Held |
| 4 | ZOOM VIDEO COMMUNICATIONS INCUSIP 98980L101 | 0.63 | 6.27% | 1.98 -33.72% | $321.29 | - | $85.96 | -1.01 | 1.50 | +$0.46B+273.75% | Reduced |
| 5 | ENSTAR GROUP LIMITEDESGR | 0.43 | 4.26% | 1.75 - | $246.73 | $22.00 -91.08% | $184.97 | 0.00 | 2.25 | -$0.28B-88.11% | Held |
| 6 | Uber Technologies, Inc.UBER | 0.37 | 3.66% | 6.79 -41.95% | $54.51 | $73.03 +33.98% | $29.85 | -4.91 | 1.75 | +$0.29B+144.64% | Reduced |
| 7 | JD.com, Inc.JD | 0.35 | 3.47% | 4.16 -69.36% | $84.33 | $33.07 -60.79% | $55.48 | -9.42 | 2.50 | -$0.09B-40.39% | Reduced |
| 8 | CHINA BIOLOGIC PRODS HLDGS ICBPO | 0.35 | 3.47% | 2.96 - | $118.41 | - | $77.78 | 0.00 | 2.50 | +$0.12B+52.24% | Held |
| 9 | BridgeBio Pharma, Inc.BBIO | 0.33 | 3.26% | 5.36 +13.80% | $61.60 | $54.92 -10.84% | $20.26 | +0.65 | 2.00 | +$0.19B+171.13% | Increased |
| 10 | NOVABRIDGE BIOSCIENCESNBP | 0.32 | 3.17% | 6.62 +342.10% | $48.47 | - | $48.14 | +5.12 | 0.75 | +$0.00B+0.68% | Increased |
| 11 | KE Holdings Inc.BEKE | 0.29 | 2.82% | 5.01 +0.24% | $56.98 | $18.29 -67.90% | $61.29 | +0.01 | 0.75 | -$0.22B-70.16% | Increased |
| 12 | GDS Holdings LimitedGDS | 0.25 | 2.52% | 3.14 - | $81.09 | $35.45 -56.28% | $81.78 | 0.00 | 1.00 | -$0.15B-56.65% | Held |
| 13 | Salesforce, Inc.CRM | 0.24 | 2.38% | 1.14 +6.01% | $211.87 | $210.90 -0.46% | $186.02 | +0.06 | 1.25 | +$0.03B+13.38% | Increased |
| 14 | Bilibili Inc.BILI | 0.21 | 2.11% | 2.00 -50.48% | $107.06 | $27.05 -74.73% | $30.91 | -2.04 | 2.50 | -$0.01B-12.50% | Reduced |
| 15 | Apellis Pharmaceuticals, Inc.APLS | 0.20 | 1.93% | 4.56 -9.35% | $42.91 | $24.52 -42.86% | $19.13 | -0.47 | 2.50 | +$0.02B+28.21% | Reduced |
| 16 | Beam Therapeutics Inc.BEAM | 0.17 | 1.64% | 2.07 -30.13% | $80.04 | $25.98 -67.54% | $18.00 | -0.89 | 1.25 | +$0.02B+44.33% | Reduced |
| 17 | DoorDash, Inc.DASH | 0.14 | 1.42% | 1.10 +27.70% | $131.13 | $154.61 +17.91% | $140.23 | +0.24 | 0.50 | +$0.02B+10.25% | Increased |
| 18 | FibroGen, Inc.FGEN | 0.14 | 1.36% | 3.96 - | $34.71 | $10.38 -70.09% | $43.86 | 0.00 | 2.50 | -$0.13B-76.33% | Held |
| 19 | Mondelez International, Inc.MDLZ | 0.11 | 1.08% | 1.86 -9.42% | $58.53 | $62.41 +6.63% | $40.03 | -0.19 | 2.50 | +$0.04B+55.91% | Reduced |
| 20 | argenx SEARGX | 0.10 | 1.02% | 0.38 -20.10% | $275.39 | $843.66 +206.35% | $218.35 | -0.09 | 1.50 | +$0.23B+286.39% | Reduced |
| 21 | KODIAK SCIENCES INCKOD | 0.10 | 1.00% | 0.89 -23.22% | $113.39 | $14.10 -87.56% | $146.91 | -0.27 | 0.50 | -$0.12B-90.40% | Reduced |
| 22 | Playtika Holding Corp.PLTK | 0.09 | 0.88% | 3.28 | $27.21 | $3.52 -87.06% | $27.21 | +3.28 | 0.25 | -$0.08B-87.06% | New |
| 23 | ZTO Express (Cayman) Inc.ZTO | 0.08 | 0.75% | 2.60 -22.26% | $29.15 | $18.98 -34.89% | $26.48 | -0.74 | 1.25 | -$0.02B-28.32% | Reduced |
| 24 | BLUEPRINT MEDICINES CORPBPMC | 0.07 | 0.73% | 0.76 -40.29% | $97.23 | - | $55.41 | -0.51 | 2.50 | +$0.03B+75.47% | Reduced |
| 25 | Gossamer Bio, Inc.GOSS | 0.07 | 0.68% | 7.42 - | $9.25 | $2.19 -76.32% | $16.64 | 0.00 | 2.25 | -$0.11B-86.84% | Held |
Showing 1-25 of 91
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2021 Q1.
| 1 | TAL Education GroupTAL | 4.06 | 2.25 | $65.79 | $53.85 | -$0.05B-18.15% |
| 2 | Align Technology, Inc.ALGN | 0.18 | 1.50 | $855.10 | $541.53 | -$0.06B-36.67% |
| 3 | VIELA BIO INCVIE | 2.38 | 1.25 | $27.15 | $35.97 | +$0.02B+32.49% |
| 4 | Sea LimitedSE | 0.34 | 2.00 | $189.73 | $223.23 | +$0.01B+17.66% |
| 5 | 17 Education & Technology Group Inc.YQ | 4.64 | 0.25 | $12.81 | $7.14 | -$0.03B-44.27% |
| 6 | MercadoLibre, Inc.MELI | 0.03 | 0.50 | $1082.47 | $1472.14 | +$0.01B+36.00% |
| 7 | Zillow Group, Inc.Z | 0.30 | 0.50 | $101.59 | $129.80 | +$0.01B+27.77% |
| 8 | AbCellera Biologics Inc.ABCL | 0.60 | 0.25 | $40.24 | $40.24 | $0.00B0.00% |
| 9 | EIDOS THERAPEUTICS INCEIDX | 0.18 | 2.25 | $13.76 | $131.58 | +$0.02B+856.06% |
| 10 | BERKELEY LTS INCBLI | 0.20 | 0.50 | $76.36 | $89.41 | +$0.00B+17.09% |
| 11 | 10x Genomics, Inc.TXG | 0.07 | 1.50 | $50.40 | $141.60 | +$0.01B+180.95% |
| 12 | G1 THERAPEUTICS INCGTHX | 0.47 | 2.25 | $38.30 | $17.99 | -$0.01B-53.03% |
| 13 | FUTU HOLDINGS LTDFUTU | 0.15 | 0.50 | $28.62 | $158.82 | +$0.02B+454.93% |
| 14 | Atea Pharmaceuticals, Inc.AVIR | 0.13 | 0.25 | $41.78 | $41.78 | $0.00B0.00% |
| 15 | ATHENEX INCATNX | 0.43 | 0.50 | $12.10 | $11.06 | -$0.00B-8.60% |
| 16 | CELLULAR BIOMEDICINE GROUP ICBMG | 0.24 | 1.50 | $14.86 | $18.38 | +$0.00B+23.69% |
| 17 | CureVac N.V.CVAC | 0.05 | 0.50 | $46.55 | $81.08 | +$0.00B+74.17% |
Showing 1-17 of 17
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.